3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
3
Lymphoma
3
Preleukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Esophageal Neoplasms
2
Bone Marrow Diseases
2
Sarcoma
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Interventions
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
cabozantinib
2
aldesleukin
2
Specimen Handling
2
CTLA-4 Antigen
2
Adoptive Transfer
2
niraparib
1
lenvatinib
1
entinostat
1
enfortumab vedotin
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
avelumab
1
Psychiatric Nursing
1
Platinum
1
Physical Therapy Modalities
1
Palliative Care
1
Paclitaxel
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Cisplatin
1
CP protocol
1
Biopsy
1
BAY 1895344
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Penile Neoplasms
×
Patient Reported Outcome Measures
×
1 year
×
Clear all
No trials found.